Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy
In this episode of Women Leaders in Oncology, recorded during ASCO 2025, Nina Mojas, Senior Vice President of Oncology Global Product Strategy at GSK, shares insights on the company’s evolving oncology portfolio and her personal journey as a leader in the industry.
GSK re-entered oncology just 5–6 years ago and is now rapidly expanding its presence across multiple disease areas. Nina discusses how the company is building its pipeline through both in-house innovation and external partnerships — and why this growth phase is one of the most exciting chapters of her career.
Key topics covered:
- GSK’s oncology strategy: from gynecologic cancers to hematologic malignancies
- Expansion into ovarian cancer, endometrial cancer, myelofibrosis, and multiple myeloma
- How GSK balances internal R&D with business development and external innovation
- The challenges and rewards of rebuilding a major oncology portfolio
- Leadership reflections: being a woman leader and a single mother in a demanding industry
- The importance of workplace flexibility and choosing the right team culture
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 1, 2025, 10:32
Jul 1, 2025, 09:57
Jul 1, 2025, 09:25